Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...
Hosted on MSN11mon
FDA puts partial clinical hold on Roche/Genentech MS drugRoche’s (OTCQX:RHHBY) Genentech subsidiary said the FDA has placed a partial clinical hold on its development program for the drug fenebrutinib in the treatment of multiple sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback